Endogenous sex hormones and risk of venous thromboembolism in young women

Luuk J.J. Scheres; Astrid van Hylckama Vlieg; Bart E.P.B. Ballieux; Bart C.J.M. Fauser; Frits R. Rosendaal; Saskia Middeldorp; Suzanne C. Cannegieter

doi:10.1111/jth.14474

Abstract

1 min read

The risk of venous thromboembolism (VTE) in young women can predominantly be attributed to exogenous hormone use. The influence of (abnormalities in) endogenous sex hormones, as in polycystic ovary syndrome (PCOS) or primary ovarian insufficiency (POI), on VTE risk is uncertain.

Related publications

Article2013

Venous thromboembolism in women: a specific reproductive health risk

Sabine Eichinger, J.L.H. Evers, A Glasier, Carlo La Vecchia, Ida Martinelli, Sven O. Skouby, Edgardo Somigliana, DavidT. Baird, G. Benagiano, P. G. Crosignani, Luca Gianaroli, Eva Negri, Annibale Volpe, Anna Glasier, P. G. Crosignani

Article2025

Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease

Ralf Weiskirchen, Amedeo Lonardo

Article2002

Female Hormones and Thrombosis

Frits R. Rosendaal, Frans M. Helmerhorst, Jan P. Vandenbroucke

Arteriosclerosis Thrombosis and Vascular Biology

Article2025

Sex Differences in MASLD

Amedeo Lonardo, Mohamad Jamalinia, Ralf Weiskirchen

Article2021

Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm

Marika Paalanne, Marja Vääräsmäki, Sanna Mustaniemi, Marjaana Tikanmäki, Karoliina Wehkalampi, Hanna‐Maria Matinolli, Johan G. Eriksson, Paul M Ridker, Laure Morin‐Papunen, Eero Kajantie